Analysis of the first subset of linked SEER patient data demonstrates DecisionDx®-Melanoma testing was associated with improved overall survival rates compared to untested patients DecisionDx-Melanoma ...
Categorizing patients with cancer by their disease stage can be an important tool when conducting administrative claims-based studies. As claims databases frequently do not capture this information, ...
Assessment of performance measures for patients with the myelodysplastic syndrome (MDS) in the United States. Background: SEER data has been used to suggest underuse and racial disparities in receipt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results